On Monday, Avon Products Inc. (NYSE:AVP)’s shares surged 1.39% to $8.01, after a leading global beauty company, recently declared that it has decided to postpone to Fall 2015 its Investor Day that the Company was originally planned to host on May 13, 2015. The decision to postpone the meeting follows the recent appointment of James S. Scully as the Company’s Chief Financial Officer, to allow the Company adequate time to prepare for a more robust discussion at the meeting. Further details, counting webcast information, will be declared closer to the event.
Avon will provide an update on its turnaround progress when it reports first-quarter 2015 financial results on April 30, 2015.
Avon Products, Inc. manufactures and markets beauty and related products worldwide. It offers beauty products, such as skincare, and personal care products, in addition to fragrances and color cosmetics; and fashion and home products comprising of jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products, and nutritional products.
Commerce Bancshares, Inc. (NASDAQ:CBSH)’s shares gained 1.38% to $42.46, during the last trading session on Monday, after Commerce Bancshares declared earnings of $.61 per ordinary share for the three months ended March 31, 2015 contrast to $.62 per share in the preceding quarter and $.64 per share in the first quarter of 2014. Net revenue attributable to Commerce Bancshares, Inc. for the first quarter amounted to $61.1 million, contrast to $62.7 million in the preceding quarter and $64.3 million in the same quarter last year. For the quarter, the return on average assets was 1.05%, the return on average ordinary equity was 10.7% and the efficiency ratio was 64.6%.
Total assets at March 31, 2015 were $24.0 billion, total loans were $11.7 billion, and total deposits were $19.6 billion. During the quarter, the Company paid a ordinary cash dividend of $.225 per share, representing a 5% raise over the rate paid in 2014 and also paid a 6% cash dividend on its preferred stock, issued in 2014.
Commerce Bancshares, Inc. operates as the bank holding company for Commerce Bank that provides retail, corporate, investment, trust, and asset administration products and services to individuals and businesses. It operates through three segments: Consumer, Commercial, and Wealth.
At the end of Monday’s trade, DepoMed Inc. (NASDAQ:DEPO)’s shares gained 1.38% to $25.06, hitting its highest level, after a specialty pharmaceutical company, declared it has reached a settlement contract with Actavis, Inc. in Depomed’s patent infringement litigation related to Actavis’s Abbreviated New Drug Application seeking approval to market generic versions of Depomed’s Gralise® (gabapentin) 300 mg and 600 mg tablets. The settlement permits Actavis to start selling generic versions of Gralise on January 1, 2024, or earlier under certain circumstances.
The settlement dismisses Actavis’s pending appeal with the United States Court of Appeals for the Federal Circuit of the August 2014 trial court decision finding all seven Depomed patents asserted in the litigation, which expire between 2016 and February 2024, to be valid and infringed. The settlement contract is subject to review by the U.S. Department of Justice and the Federal Trade Commission, and entry of orders dismissing the appeal and related federal district court litigation.
In April 2014, Depomed declared settlements with two other Gralise ANDA filers providing for generic entry on January 1, 2024. Upon dismissal of the Actavis litigation, all pending Gralise ANDA litigation will have been resolved.
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the administration of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults.
Finally, Investors Bancorp Inc. (NASDAQ:ISBC), ended its Monday’s trading session with 1.36% gain, and closed at $11.89, after the holding company declared that it anticipates to report earnings for the first quarter ended March 31, 2015, on Thursday, April 30, 2015 at about 5:00 p.m. Eastern Time (ET).
The Company also declared that it will host an earnings conference call on Friday, May 1, 2015 at 11:00 a.m. (ET). We encourage participants to pre-register for the conference call by using the link below to receive a unique dial-in number and PIN. Callers who pre-register will bypass the live operator and may avoid any delays in joining the conference call. Participants will right away receive an online confirmation, an email and a calendar invitation for the event.
Investors Bancorp, Inc. operates as the holding company for Investors Bank that provides various banking products and services for businesses and individuals in the United States. It offers deposit products, such as savings, checking, and money market accounts, in addition to certificates of deposit.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
